News | September 09, 2013

Loma Linda University Medical Center Explores New Frontiers in Proton Therapy

Nation’s First Hospital-Based Proton Therapy Center Takes Lead in Developing More Precise Proton Scanning Beam

September 9, 2013 — More than two decades after becoming the world’s first hospital-based proton therapy center, the engineers, scientists and physicians at Loma Linda University Medical Center (LLUMC) continue to develop new technologies that will lead to the next generation of proton therapy treatment.

Because of its pinpoint accuracy, proton therapy today is a highly effective form of treatment for two main reasons: one, there is significantly less radiation to surrounding healthy tissues; and two, it has the ability to take care of many types of tumors found in adults and children often considered difficult to treat with standard radiation therapies.

“One might think that all proton beams are created equal, but that’s not the case,” said Jerry D. Slater, M.D., chairman of the LLUMC Proton Treatment & Research Center. “Scatter beam technology was the first type of technology we developed, and we still consider it the most effective proton therapy beam available for many types of tumors. But as far back as 1985, we were looking at active beam scanning (ABS) technology for use at LLUMC to provide another tool for oncologists to use to maximize treatment benefits.”

As a leader in proton beam development, LLUMC’s research is committed to creating the most effective proton delivery methods. As such, LLUMC has spent considerable time and resources studying the potential of ABS technology and has developed a scanning-beam delivery system with superior resolution and spot size. LLUMC’s ABS technology provides our physicians with a tool to irradiate complex tumors with superior conformity and without the need for an aperture. When the technology is approved for use at LLUMC, the proton treatment center will be able to offer the patient a completely personalized treatment using either ABS or scatter beam technology combined with the experience that comes from being the first hospital-based proton center.

“Our research is showing the promise of ABS technology specifically for certain large and irregularly shaped tumor sites. But for certain smaller-scale targets, the scatter beam could still be the most effective treatment option for patients,” Slater said. As a consequence, doctors anticipate that the scatter beam will be utilized to deliver the necessary radiation approximately 70-85 percent of the time.

“As we have done throughout our history, we will continue to search for new frontiers in proton therapy and through clinical research bring the best of what we’ve learned to our patients in a safe and efficient way,” said Slater.

For more information, visit:

Related Content

Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
RaySearch Releases RayStation 7 Radiotherapy Treatment Planning System
Technology | Treatment Planning | December 19, 2017
RayStation 7, the latest release of RaySearch’s radiation therapy treatment planning system, adds new functionality and...
Baptist Hospital's Miami Cancer Institute Treats First Patient With Proteus Plus Proton Therapy
News | Proton Therapy | December 19, 2017
December 19, 2017 — IBA (Ion Beam Applications SA) announced that Miami Cancer Institute treated its first patients,
Mevion Achieves CE Mark for S250i Proton Therapy System
News | Proton Therapy | November 21, 2017
November 21, 2017 — Mevion Medical Systems announced the Mevion S250i...
RayStation Selected for New Tennessee Proton Therapy Center
News | Treatment Planning | November 20, 2017
November 20, 2017 — Provision Healthcare has selected RayStation for external beam planning at the new Provision Care
Proton therapy doesn’t get as near to the heart and other internal organs as X-ray therapy does. (Image courtesy of Provision Cares Proton Therapy Center.)

Proton therapy doesn’t get as near to the heart and other internal organs as X-ray therapy does. (Image courtesy of Provision Cares Proton Therapy Center.)

Feature | Proton Therapy | November 06, 2017 | By Larisa Brass, MPH
Thirty-three. Twenty-nine. Sixty-four. These are the ages of the breast cancer patients who have walked through the...
PTCOG-NA Studies Address Cost and Coverage Issues With Proton Therapy
News | Proton Therapy | November 01, 2017
Physicians from across the country gathered in Chicago last week to discuss the most recent advances in proton therapy...
Proton Therapy Lowers Treatment Side Effects in Pediatric Head and Neck Cancer Patients
News | Proton Therapy | November 01, 2017
Pediatric patients with head and neck cancer can be treated with proton beam therapy (PBT) instead of traditional...
Proton Therapy Shows Promising Clinical Benefits for Esophageal, Prostate and Breast Cancer
News | Proton Therapy | October 30, 2017
The National Association for Proton Therapy (NAPT) announced a number of clinical papers showing promising results were...
Overlay Init